About: Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1990

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1990 (uk) im Jahr 1990 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1990 (ast) artikull shkencor i botuar më 01 janar 1990 (sq) scientific article published on 01 January 1990 (en)
publication date	wds:Q68925952-A3F7737E-19E5-4552-B083-8B40FC9DAAEA
publication date	1990-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q68925952-25E75684-6909-4270-B84F-C02131E6D2FB
language of work or name	English
cites work	wds:Q68925952-0BC15018-EE38-47BA-AC7A-E0AF96AD7300 wds:Q68925952-3CF7A519-E1F2-48DC-AAFE-55E21D4AAC8F wds:Q68925952-45223F29-461A-40D9-8425-12E93381C107 wds:Q68925952-6638EF3F-E6CF-4982-BF2A-8BF63D55D420 wds:Q68925952-84C8F22F-FA69-40FA-8600-CC604BF6F82A wds:Q68925952-8A8F570F-3B4D-4AC3-A480-08ED767E6FBB wds:Q68925952-91625023-0BF9-4780-99CA-D2429131CBC0 wds:Q68925952-9650EF3F-EB73-461B-9B32-94006E3EDD59 wds:Q68925952-ADF69394-D206-49A6-9588-D28542E0BD09 wds:Q68925952-BCCC0926-1906-46C5-9D95-A85091AF6991 wds:Q68925952-DCE214D9-CB40-4BC5-8733-85A4AE29F676 wds:Q68925952-FCD8FD90-5B72-43D7-BD5F-EAB469A7DD5E
cites work	Ultrastructural immunocytochemical analysis of lymphocytes infiltrating bile duct epithelia in primary biliary cirrhosis Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis Specificity of monoclonal antibodies directed against human and murine class II histocompatibility antigens as analyzed by binding to HLA-deletion mutant cell lines Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity A Molecular Basis for MHC Class II—Associated Autoimmunity Is ursodeoxycholic acid an effective treatment for primary biliary cirrhosis? Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies Expression of blood group antigens including HLA markers in human adult liver Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody Hepatic beta 2-microglobulin distribution in primary biliary cirrhosis Distinct HLA-DR epitopes and distinct families of HLA-DR molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak crossreacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differenti Increased expression of major histocompatibility antigens in the liver as a result of cholestasis
author name string	wds:Q68925952-0387D88B-F1D7-496B-BB4A-3C11699663AB wds:Q68925952-0676383B-9785-47D3-A323-CF866E392464 wds:Q68925952-31F4E34F-6C36-4553-8A78-F3445E86D45B wds:Q68925952-8B5739AA-2D14-436A-91D9-6A2AE55EE2BD
author name string	R Poupon P Rouger Y Calmus P Gane
rdfs:label	Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid (en) Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid (nl) Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid (sq)
skos:prefLabel	Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid (en) Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid (nl) Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid (sq)
name	Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid (en) Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid (nl) Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid (sq)
title	wds:Q68925952-815097CB-20D4-4A40-820E-53D8EECC43F8
title	Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid (en)
page(s)	wds:Q68925952-AA92C811-C8B9-4E50-A60B-2754D2C9D481
page(s)	12-15
instance of	wds:Q68925952-882E83DB-CB87-42C8-ADC7-468AEEFFF149
instance of	scholarly article
main subject	wds:Q68925952-5A5552DC-FFD0-427B-8EB2-2B7499A0227E
main subject	primary biliary cholangitis
PubMed ID	wds:Q68925952-7E6B5C6F-0827-4E1A-B938-8892DFEA40E1
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2403961
PubMed ID	2403961
published in	wds:Q68925952-8636D198-5EE2-4DC0-9317-782FA2B38DC5
published in	Hepatology
issue	wds:Q68925952-C27D9481-7851-4DE4-A18D-6BEB400C09D8
volume	wds:Q68925952-89070160-CCCC-4DDB-9D3A-815E1F2C6101
issue	1
volume	11
DOI	wds:Q68925952-D3879A7A-E09E-4308-8D78-F2C709E5901C
DOI	http://dx.doi.org/10.1002/HEP.1840110104
DOI	10.1002/HEP.1840110104
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68925952
is cites work of	Bile-acid-induced cell injury and protection Ursodeoxycholic acid treatment lowers the serum level of antibodies against pyruvate dehydrogenase and influences their inhibitory capacity for the enzyme complex in patients with primary biliary cirrhosis Bile acids for primary sclerosing cholangitis Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis Treatment of primary sclerosing cholangitis with low-dose ursodeoxycholic acid: results of a retrospective Italian multicentre survey Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial Single or multiple dose ursodeoxycholic acid for cholestatic liver disease: biliary enrichment and biochemical response Immunomodulatory effects of ursodeoxycholic acid on immune responses Bile acids for viral hepatitis Bile acids for primary sclerosing cholangitis Effects of ursodeoxycholic acid (ursodiol) treatment on chronic viral hepatitis in heart transplant patients: results of a prospective, double-blind, placebo-randomized study The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis. A 12-month double-blind, placebo-controlled trial Molecular mechanisms of ursodeoxycholic acid toxicity & side effects: ursodeoxycholic acid freezes regeneration & induces hibernation mode. Mechanism of hepatoprotective action of bile salts in liver disease Management of graft-versus-host disease in paediatric bone marrow transplant recipients Ursodeoxycholic acid therapy in pregnant women with cholestasis. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis Efficacy of ursodeoxycholic acid therapy in chronic viral hepatitis C with high serum gamma-glutamyltranspeptidase levels Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis Use of ursodeoxycholic acid in patients with liver disease Pruritus associated with cholestasis. A review of pathogenesis and management Ursodeoxycholic acid therapy in hepatobiliary disease Primary biliary cirrhosis and bile acids

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software